3-but-2-ynyl-5-(2-hydroxyethyl)-2-piperidin-1-ylimidazo[4,5-d]pyridazin-4-one;3-but-2-ynyl-5-(2-methoxyethyl)-2-piperidin-1-ylimidazo[4,5-d]pyridazin-4-one;3-but-2-ynyl-5-(2-phenoxyethyl)-2-piperidin-1-ylimidazo[4,5-d]pyridazin-4-one;3-but-2-ynyl-5-(2-phenylethyl)-2-piperidin-1-ylimidazo[4,5-d]pyridazin-4-one;ethyl 2-(3-but-2-ynyl-4-oxo-2-piperidin-1-ylimidazo[4,5-d]pyridazin-5-yl)acetate;pentakis(2,2,2-trifluoroacetic acid)
C105H122F15N25O20 — CID 158942654
Data last refreshed: (MolForge compound catalog, from PubChem)
About 3-but-2-ynyl-5-(2-hydroxyethyl)-2-piperidin-1-ylimidazo[4,5-d]pyridazin-4-one;3-but-2-ynyl-5-(2-methoxyethyl)-2-piperidin-1-ylimidazo[4,5-d]pyridazin-4-one;3-but-2-ynyl-5-(2-phenoxyethyl)-2-piperidin-1-ylimidazo[4,5-d]pyridazin-4-one;3-but-2-ynyl-5-(2-phenylethyl)-2-piperidin-1-ylimidazo[4,5-d]pyridazin-4-one;ethyl 2-(3-but-2-ynyl-4-oxo-2-piperidin-1-ylimidazo[4,5-d]pyridazin-5-yl)acetate;pentakis(2,2,2-trifluoroacetic acid)
3-but-2-ynyl-5-(2-hydroxyethyl)-2-piperidin-1-ylimidazo[4,5-d]pyridazin-4-one;3-but-2-ynyl-5-(2-methoxyethyl)-2-piperidin-1-ylimidazo[4,5-d]pyridazin-4-one;3-but-2-ynyl-5-(2-phenoxyethyl)-2-piperidin-1-ylimidazo[4,5-d]pyridazin-4-one;3-but-2-ynyl-5-(2-phenylethyl)-2-piperidin-1-ylimidazo[4,5-d]pyridazin-4-one;ethyl 2-(3-but-2-ynyl-4-oxo-2-piperidin-1-ylimidazo[4,5-d]pyridazin-5-yl)acetate;pentakis(2,2,2-trifluoroacetic acid) (PubChem CID 158942654) has the molecular formula C105H122F15N25O20 and a molecular weight of 2339.26 g/mol. Its IUPAC name is 3-but-2-ynyl-5-(2-hydroxyethyl)-2-piperidin-1-ylimidazo[4,5-d]pyridazin-4-one;3-but-2-ynyl-5-(2-methoxyethyl)-2-piperidin-1-ylimidazo[4,5-d]pyridazin-4-one;3-but-2-ynyl-5-(2-phenoxyethyl)-2-piperidin-1-ylimidazo[4,5-d]pyridazin-4-one;3-but-2-ynyl-5-(2-phenylethyl)-2-piperidin-1-ylimidazo[4,5-d]pyridazin-4-one;ethyl 2-(3-but-2-ynyl-4-oxo-2-piperidin-1-ylimidazo[4,5-d]pyridazin-5-yl)acetate;pentakis(2,2,2-trifluoroacetic acid).
Molecular Properties
| Compound Name | 3-but-2-ynyl-5-(2-hydroxyethyl)-2-piperidin-1-ylimidazo[4,5-d]pyridazin-4-one;3-but-2-ynyl-5-(2-methoxyethyl)-2-piperidin-1-ylimidazo[4,5-d]pyridazin-4-one;3-but-2-ynyl-5-(2-phenoxyethyl)-2-piperidin-1-ylimidazo[4,5-d]pyridazin-4-one;3-but-2-ynyl-5-(2-phenylethyl)-2-piperidin-1-ylimidazo[4,5-d]pyridazin-4-one;ethyl 2-(3-but-2-ynyl-4-oxo-2-piperidin-1-ylimidazo[4,5-d]pyridazin-5-yl)acetate;pentakis(2,2,2-trifluoroacetic acid) |
|---|---|
| PubChem CID | 158942654 |
| Molecular Formula | C105H122F15N25O20 |
| Molecular Weight | 2339.26 g/mol |
| Exact Mass | 2337.91 |
| IUPAC Name | 3-but-2-ynyl-5-(2-hydroxyethyl)-2-piperidin-1-ylimidazo[4,5-d]pyridazin-4-one;3-but-2-ynyl-5-(2-methoxyethyl)-2-piperidin-1-ylimidazo[4,5-d]pyridazin-4-one;3-but-2-ynyl-5-(2-phenoxyethyl)-2-piperidin-1-ylimidazo[4,5-d]pyridazin-4-one;3-but-2-ynyl-5-(2-phenylethyl)-2-piperidin-1-ylimidazo[4,5-d]pyridazin-4-one;ethyl 2-(3-but-2-ynyl-4-oxo-2-piperidin-1-ylimidazo[4,5-d]pyridazin-5-yl)acetate;pentakis(2,2,2-trifluoroacetic acid) |
| SMILES | CC#CCn1c(N2CCCCC2)nc2cnn(CC(=O)OCC)c(=O)c21.CC#CCn1c(N2CCCCC2)nc2cnn(CCO)c(=O)c21.CC#CCn1c(N2CCCCC2)nc2cnn(CCOC)c(=O)c21.CC#CCn1c(N2CCCCC2)nc2cnn(CCOc3ccccc3)c(=O)c21.CC#CCn1c(N2CCCCC2)nc2cnn(CCc3ccccc3)c(=O)c21.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F |
| InChI | InChI=1S/C22H25N5O2.C22H25N5O.C18H23N5O3.C17H23N5O2.C16H21N5O2.5C2HF3O2/c1-2-3-14-26-20-19(24-22(26)25-12-8-5-9-13-25)17-23-27(21(20)28)15-16-29-18-10-6-4-7-11-18;1-2-3-15-26-20-19(24-22(26)25-13-8-5-9-14-25)17-23-27(21(20)28)16-12-18-10-6-4-7-11-18;1-3-5-11-22-16-14(20-18(22)21-9-7-6-8-10-21)12-19-23(17(16)25)13-15(24)26-4-2;1-3-4-10-21-15-14(13-18-22(16(15)23)11-12-24-2)19-17(21)20-8-6-5-7-9-20;1-2-3-9-20-14-13(12-17-21(10-11-22)15(14)23)18-16(20)19-7-5-4-6-8-19;5*3-2(4,5)1(6)7/h4,6-7,10-11,17H,5,8-9,12-16H2,1H3;4,6-7,10-11,17H,5,8-9,12-16H2,1H3;12H,4,6-11,13H2,1-2H3;13H,5-12H2,1-2H3;12,22H,4-11H2,1H3;5*(H,6,7) |
| InChIKey | IVVRLXHSGXVRII-UHFFFAOYSA-N |
| XLogP | 11.72 |
| TPSA | 531.24 Ų |
| H-Bond Donors | 6 |
| H-Bond Acceptors | 40 |
| Rotatable Bonds | 25 |
| Heavy Atoms | 165 |
| Complexity | — |
Lipinski Rule of Five
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2339.26 |
| LogP ≤ 5 | 11.72 |
| H-Bond Donors ≤ 5 | 6 |
| H-Bond Acceptors ≤ 10 | 40 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'triple_bond', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 158942654 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.